190 related articles for article (PubMed ID: 31816412)
1. Aquaporin-9 is involved in the lipid-lowering activity of the nutraceutical silybin on hepatocytes through modulation of autophagy and lipid droplets composition.
Baldini F; Portincasa P; Grasselli E; Damonte G; Salis A; Bonomo M; Florio M; Serale N; Voci A; Gena P; Vergani L; Calamita G
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Mar; 1865(3):158586. PubMed ID: 31816412
[TBL] [Abstract][Full Text] [Related]
2. Silybin counteracts lipid excess and oxidative stress in cultured steatotic hepatic cells.
Vecchione G; Grasselli E; Voci A; Baldini F; Grattagliano I; Wang DQ; Portincasa P; Vergani L
World J Gastroenterol; 2016 Jul; 22(26):6016-26. PubMed ID: 27468193
[TBL] [Abstract][Full Text] [Related]
3. The Nutraceutic Silybin Counteracts Excess Lipid Accumulation and Ongoing Oxidative Stress in an
Vecchione G; Grasselli E; Cioffi F; Baldini F; Oliveira PJ; Sardão VA; Cortese K; Lanni A; Voci A; Portincasa P; Vergani L
Front Nutr; 2017; 4():42. PubMed ID: 28971098
[TBL] [Abstract][Full Text] [Related]
4. Silybin Alleviates Hepatic Steatosis and Fibrosis in NASH Mice by Inhibiting Oxidative Stress and Involvement with the Nf-κB Pathway.
Ou Q; Weng Y; Wang S; Zhao Y; Zhang F; Zhou J; Wu X
Dig Dis Sci; 2018 Dec; 63(12):3398-3408. PubMed ID: 30191499
[TBL] [Abstract][Full Text] [Related]
5. Excess fructose and fatty acids trigger a model of non‑alcoholic fatty liver disease progression in vitro: Protective effect of the flavonoid silybin.
Grasselli E; Baldini F; Vecchione G; Oliveira PJ; Sardão VA; Voci A; Portincasa P; Vergani L
Int J Mol Med; 2019 Aug; 44(2):705-712. PubMed ID: 31173180
[TBL] [Abstract][Full Text] [Related]
6. Non-Alcoholic Fatty Liver Disease.
Engin A
Adv Exp Med Biol; 2017; 960():443-467. PubMed ID: 28585211
[TBL] [Abstract][Full Text] [Related]
7. Silybin Modulates Collagen Turnover in an In Vitro Model of NASH.
Anfuso B; Giraudi PJ; Tiribelli C; Rosso N
Molecules; 2019 Apr; 24(7):. PubMed ID: 30986937
[TBL] [Abstract][Full Text] [Related]
8. Reduced hepatic aquaporin-9 and glycerol permeability are related to insulin resistance in non-alcoholic fatty liver disease.
Rodríguez A; Gena P; Méndez-Giménez L; Rosito A; Valentí V; Rotellar F; Sola I; Moncada R; Silva C; Svelto M; Salvador J; Calamita G; Frühbeck G
Int J Obes (Lond); 2014 Sep; 38(9):1213-20. PubMed ID: 24418844
[TBL] [Abstract][Full Text] [Related]
9. Silybin ameliorates hepatic lipid accumulation and modulates global metabolism in an NAFLD mouse model.
Sun R; Xu D; Wei Q; Zhang B; Aa J; Wang G; Xie Y
Biomed Pharmacother; 2020 Mar; 123():109721. PubMed ID: 31865143
[TBL] [Abstract][Full Text] [Related]
10. Involvement of Lipophagy and Chaperone-Mediated Autophagy in the Pathogenesis of Non-Alcoholic Fatty Liver Disease by Regulation of Lipid Droplets.
Mastoridou EM; Goussia AC; Kanavaros P; Charchanti AV
Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958873
[TBL] [Abstract][Full Text] [Related]
11. Compounds that modulate AMPK activity and hepatic steatosis impact the biosynthesis of microRNAs required to maintain lipid homeostasis in hepatocytes.
Latorre J; Ortega FJ; Liñares-Pose L; Moreno-Navarrete JM; Lluch A; Comas F; Oliveras-Cañellas N; Ricart W; Höring M; Zhou Y; Liebisch G; Nidhina Haridas PA; Olkkonen VM; López M; Fernández-Real JM
EBioMedicine; 2020 Mar; 53():102697. PubMed ID: 32143184
[TBL] [Abstract][Full Text] [Related]
12. The role of hepassocin in the development of non-alcoholic fatty liver disease.
Wu HT; Lu FH; Ou HY; Su YC; Hung HC; Wu JS; Yang YC; Wu CL; Chang CJ
J Hepatol; 2013 Nov; 59(5):1065-72. PubMed ID: 23792031
[TBL] [Abstract][Full Text] [Related]
13. Combinational applicaton of silybin and tangeretin attenuates the progression of non-alcoholic steatohepatitis (NASH) in mice via modulating lipid metabolism.
Suguro R; Pang XC; Yuan ZW; Chen SY; Zhu YZ; Xie Y
Pharmacol Res; 2020 Jan; 151():104519. PubMed ID: 31706011
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-122 Inhibits Lipid Droplet Formation and Hepatic Triglyceride Accumulation via Yin Yang 1.
Wu GY; Rui C; Chen JQ; Sho E; Zhan SS; Yuan XW; Ding YT
Cell Physiol Biochem; 2017; 44(4):1651-1664. PubMed ID: 29216638
[TBL] [Abstract][Full Text] [Related]
15. Triclocarban induces lipid droplet accumulation and oxidative stress responses by inhibiting mitochondrial fatty acid oxidation in HepaRG cells.
Nakamura H; Matsui T; Shinozawa T
Toxicol Lett; 2024 May; 396():11-18. PubMed ID: 38631510
[TBL] [Abstract][Full Text] [Related]
16. Protein kinase MST3 modulates lipid homeostasis in hepatocytes and correlates with nonalcoholic steatohepatitis in humans.
Cansby E; Kulkarni NM; Magnusson E; Kurhe Y; Amrutkar M; Nerstedt A; Ståhlman M; Sihlbom C; Marschall HU; Borén J; Blüher M; Mahlapuu M
FASEB J; 2019 Sep; 33(9):9974-9989. PubMed ID: 31173506
[TBL] [Abstract][Full Text] [Related]
17. A unifying mathematical model of lipid droplet metabolism reveals key molecular players in the development of hepatic steatosis.
Wallstab C; Eleftheriadou D; Schulz T; Damm G; Seehofer D; Borlak J; Holzhütter HG; Berndt N
FEBS J; 2017 Oct; 284(19):3245-3261. PubMed ID: 28763157
[TBL] [Abstract][Full Text] [Related]
18. Pluripotent Stem Cell-Derived Hepatocytes Phenotypic Screening Reveals Small Molecules Targeting the CDK2/4-C/EBPα/DGAT2 Pathway Preventing ER-Stress Induced Lipid Accumulation.
Parafati M; Bae SH; Kirby RJ; Fitzek M; Iyer P; Engkvist O; Smith DM; Malany S
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33334026
[TBL] [Abstract][Full Text] [Related]
19. Estrogen prevents increased hepatic aquaporin-9 expression and glycerol uptake during starvation.
Lebeck J; Gena P; O'Neill H; Skowronski MT; Lund S; Calamita G; Praetorius J
Am J Physiol Gastrointest Liver Physiol; 2012 Feb; 302(3):G365-74. PubMed ID: 22114114
[TBL] [Abstract][Full Text] [Related]
20. Roles of organelle-specific autophagy in hepatocytes in the development and treatment of non-alcoholic fatty liver disease.
Zhang Y; Chen Y
Chin Med J (Engl); 2022 Jul; 135(14):1673-1681. PubMed ID: 35950774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
